Just-in-time Safety Planning for suicidal youths using ViraSafe
Official title: BRITE 2.0: A Just-in-time Adaptive Intervention for Suicide Safety Planning in Adolescents (ViraSafe RCT (SBIR Phase 2))
Run by Ksana Health · NCT07348666 · Data updated 2026-11-12
This study tests whether the ViraSafe app, an enhanced version of the BRITE safety planning tool, helps suicidal youths engage with coping skills and safety planning more than the original app.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 13 Years to 24 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Ksana Health Industry-sponsored |
| Locations | 3 sites (Eugene, Oregon and 2 other locations) |
| Status | Recruiting |
| Started | June 18, 2026 |
| Main results expected | December 1, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | August 12, 2026 |
| Trial ID | NCT07348666 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Youth aged 13-17 with recent suicide attempt and ideation, or young adults 18-24 with recent attempt or ideation and a plan, English-speaking, and with a willing parent/guardian or current provider to onboard them.
✕Probably not a fit
Participants without access to compatible devices or who do not engage with the app may derive little to no benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pragmatic randomized trial compares an augmented safety planning tool (ViraSafe) to the original BRITE app in adolescents and young adults at risk of suicide. ViraSafe is integrated into the Vira behavior change platform and uses just-in-time prompts and daily distress ratings to boost engagement with coping strategies and safety planning. The platform collects self-report and passive data to monitor mental health indicators and tailor support. Participants and their providers can edit, view, and access the safety plan throughout the intervention. The study is conducted across multiple clinical sites with trained providers to onboard participants to either ViraSafe or BRITE and follows participants for three months.
Why it matters
Potential benefit: If successful, participants may experience greater engagement with coping skills and more active, timely safety planning, potentially reducing suicide risk.
How similar studies have gone: Prior digital safety planning tools have shown promise; this study extends an evidence-based BRITE approach with adaptive features, representing a novel integration in a pragmatic trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Youth (minors): * 13-17 years old * Suicide attempt in the last year and ideation in the past month * English fluency and literacy * Parent or legal guardian willing and able to legally provide informed consent * Receiving care at one of the study clinical settings with trained providers to onboard ViraSafe or BRITE safety plan Youth (adults) * 18-24 years old * Recent suicide attempt or ideation with a plan * English fluency and literacy * Receiving care at one of the study clinical settings with trained providers to onboard ViraSafe or BRITE safety plan. Exclusion Criteria: Youth (minors): * Unable to read/understand English * Current manic or psychotic episode * Development disability precluding comprehension of study procedures * No routine access to a mobile phone, assessed by EHR review and during phone screen * No eligible parent or legal guardian to provide informed consent Youth (adults): * Unable to read/understand English * Current manic or psychotic episode * Development disability precluding comprehension of study procedures * No routine access to a mobile phone, assessed by EHR review and during phone screen
Where it's running
-
STAR Center, Western Psychiatric Institute & Clinic
Pittsburgh, Pennsylvania, United States Recruiting -
University of Pittsburgh
Pittsburgh, Pennsylvania, United States Recruiting -
Ksana Health Inc
Eugene, Oregon, United States Not yet recruiting
Study contacts
- Study coordinator: Stephanie Stepp, PhD
- Email: steppsd@upmc.edu
- Phone: 412-383-5051
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
A digital platform to reduce suicide risk in at-risk youth
This study is testing a new digital platform called Vira to see if it can help reduce suicide risk in teens aged 13-18 who are getting treatment for mental health issues.
-
Can tACS modulate motivation and reward signals in cannabis use disorder and depression
We’re testing whether a gentle brain stimulation method (tACS) can boost motivation and reward responses in adults with cannabis use and/or depression to see if it helps with anhedonia.
-
Friends and family training for those at risk of suicide
A six-week program tests whether training for caregivers can help them support a loved one at risk of suicide while also taking care of their own mental health.
-
iTBS to help anhedonia in depression (dual left DLPFC + OFC or left DLPFC alone)
A brain stimulation study tests whether intermittent theta burst stimulation can help people with major depression who have anhedonia, using both dual-target (left DLPFC and OFC) and single-target (left DLPFC) approaches.
-
How GLP-1 medicines affect happiness and emotional eating in people with obesity
This study follows adults starting GLP-1 weight-loss therapy to see how their feelings of pleasure and emotional eating change over 6 months.
-
Honest, Open, Proud for justice-involved veterans
This trial tests a peer-delivered stigma-reduction program for veterans with co-occurring mental health or substance use disorders who are involved with the justice system, to see if different delivery intensities help more veterans engage in care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.